- Report
- January 2024
- 165 Pages
Global
From €4797EUR$4,950USD£4,109GBP
- Report
- October 2023
- 139 Pages
Global
From €2422EUR$2,499USD£2,074GBP
- Report
- April 2024
- 263 Pages
Global
From €5427EUR$5,600USD£4,648GBP
- Report
- February 2024
- 170 Pages
Global
From €3489EUR$3,600USD£2,988GBP
- Report
- February 2024
- 114 Pages
Global
From €4603EUR$4,750USD£3,943GBP
- Report
- March 2023
- 268 Pages
Global
From €4797EUR$4,950USD£4,109GBP
- Report
- April 2023
- 293 Pages
Global
From €4797EUR$4,950USD£4,109GBP
- Report
- December 2021
- 181 Pages
Global
From €3087EUR$3,185USD£2,644GBP
€4410EUR$4,550USD£3,777GBP
- Report
- April 2023
- 76 Pages
Asia Pacific
From €4603EUR$4,750USD£3,943GBP
- Report
- April 2023
- 74 Pages
Europe
From €4603EUR$4,750USD£3,943GBP
- Report
- August 2022
- 108 Pages
Saudi Arabia
From €3247EUR$3,350USD£2,781GBP
- Report
- July 2023
- 82 Pages
Global
From €3500EUR$3,869USD£3,103GBP
- Report
- December 2023
- 204 Pages
Asia Pacific
From €2906EUR$2,999USD£2,489GBP
- Report
- December 2023
- 240 Pages
Latin America
From €2906EUR$2,999USD£2,489GBP
- Report
- March 2020
- 117 Pages
Global
From €4167EUR$4,300USD£3,569GBP
The Feline Vaccine market is a segment of the Animal Pharmaceuticals industry that focuses on the development and distribution of vaccines for cats. Vaccines are used to protect cats from a variety of diseases, including feline leukemia, rabies, and feline infectious peritonitis. Vaccines are typically administered by veterinarians, and may be given as a single dose or as a series of doses. Vaccines are also available in a variety of forms, including injectable, oral, and intranasal.
The Feline Vaccine market is highly competitive, with a number of companies offering a wide range of products. Companies in the market include Merck Animal Health, Boehringer Ingelheim, Elanco, Zoetis, and Ceva Animal Health. These companies offer a variety of vaccines, including those for feline leukemia, rabies, and feline infectious peritonitis. Show Less Read more